Gritstone bio, Inc. Common Stock
GRTS
GRTS was delisted on the 21st of October, 2024.
66 hedge funds and large institutions have $174M invested in Gritstone bio, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 21 increasing their positions, 17 reducing their positions, and 3 closing their positions.
333% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 3
24% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 17
18% more funds holding
Funds holding: 56 → 66 (+10)
0.92% less ownership
Funds ownership: 81.64% → 80.71% (-0.92%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
34% less capital invested
Capital invested by funds: $262M → $174M (-$88.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.74M |
| 2 |
BlackRock
New York
|
+$1.49M |
| 3 |
BL
Bleichroeder LP
New York
|
+$1.42M |
| 4 |
CC
Casdin Capital
New York
|
+$924K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
+$680K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.07M |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$902K |
| 3 |
UBS AM
Chicago,
Illinois
|
-$431K |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$406K |
| 5 |
Morgan Stanley
New York
|
-$256K |
GRTS Hedge Fund Activity: Q1 2020 in Review
66 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Gritstone bio, Inc. Common Stock (GRTS) for Q1 2020, worth a combined $174M — down 34% from $262M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new GRTS positions and 3 closed out — a net gain of 10 holders — while 21 added to existing stakes and 17 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $1.74M. The largest seller was Fidelity Investments, cutting an estimated $1.07M.
- 66 institutional investors held Gritstone bio, Inc. Common Stock (GRTS) as of Q1 2020, up from 56 in Q4 2019.
- Funds reported $174M of Gritstone bio, Inc. Common Stock stock for Q1 2020, down 34% quarter-over-quarter.
- 13 funds opened new Gritstone bio, Inc. Common Stock positions in Q1 2020 and 3 closed out, a net change of +10 holders.
- The largest Gritstone bio, Inc. Common Stock buyer in Q1 2020 was T. Rowe Price Associates, an estimated $1.74M added.
- The largest Gritstone bio, Inc. Common Stock seller in Q1 2020 was Fidelity Investments, an estimated $1.07M sold.
Based on aggregated 13F filings for Q1 2020.